Prenatal DHA + D3

Name: Prenatal DHA + D3
Brand: revly

Brandrevly→Fat/Fatty Acid Softgel Capsule 11 ingredients 1 caution DSLD #300218

Net contents: 90 Softgel(s)

Target: Pregnant and Lactating

DSLD entry: 2023-12-14

2 Ingredients (11)

IngredientGroupSafety

CaloriesCalories—

Total FatFat (unspecified)—

CholesterolCholesterol—

Vitamin D3Vitamin DUse with Caution

Vitamin EVitamin E (alpha tocopherol)—

Total Omega-3sOmega-3—

Eicosapentaenoic AcidEPA (Eicosapentaenoic Acid)—

Docosahexaenoic AcidDHA (Docosahexaenoic Acid)—

GelatinGelatin—

GlycerineGlycerol—

WaterWater—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Vitamin D — Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]

3 Safety cross-reference

Vitamin D — Use with Caution

⚠ Hypercalcemia at >10,000 IU/day

⚠ Vascular calcification risk

Vitamin E — Limited Evidence

⚠ Increased bleeding risk

⚠ All-cause mortality at >400 IU/day

4 Label claims

• Nutrient

• All Other

• Structure/Function

5 Data source

DSLD ID300218

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2023-12-14

6 More from revly

View revly Safety Scorecard → 2 products

Super Omega-3 Natural Lemon Flavor

7 Cite this page

Vancouver

Pkhakadze G. Prenatal DHA + D3 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 29]. Available from: https://supplement.ge/products/prenatal-dha-d3-300218/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG